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ABSTRACT 
 
The ultimate aim of the cell cycle is to create an identical daughter cell. Therefore, correct 
progression through the different phases of the cell cycle is crucial to ensure faithful cell division. 
Successful execution of the different processes in the cell cycle is achieved by the coordinated 
action of a complex network of protein kinases and phosphatases at the centre of which stand 
Cyclin-Cdk complexes. Human cells possess a variety of cyclins and Cdks, which form 
complexes that regulate cell cycle transitions.  
In an unperturbed cell cycle, preparing a cell for mitosis requires faithful DNA replication and 
reorganisation of the cell’s structures and organelles. In this scenario, cells initiate successive 
waves of Cdk activity that orchestrate the timely and spatially controlled phosphorylation of a 
multitude of targets. In contrast, upon DNA damage cells must halt cell cycle progression in order 
to prevent mitotic entry of damaged cells and subsequently avoid potential propagation of 
mutations. 
Strict control of Cyclin-Cdk complexes is, therefore, essential both for correct cell division and to 
maintain genome integrity. However, the exact mechanisms underlying the activation of Cyclin-
Cdk complexes in these different scenarios remain largely unknown. In this thesis, I have 
investigated several aspects of the regulation of Cdk activity both in the unperturbed cell cycle 
and during a DNA damage response.  
To address Cdk activity in the unperturbed cell cycle we established a novel quantitative 
immunofluorescence method and assessed the dynamics of cyclin accumulation and Cdk target 
phosphorylation in the unperturbed cell cycle. We found that the mitotic entry network first 
becomes activated at the S/G2 transition. This finding shifts the classical view of an abrupt Cdk 
activation at mitotic entry to an earlier and more gradual activation. Furthermore, it provides a 
potential link between S phase and mitosis, suggesting the existence of a mechanism that 
maintains pro-mitotic activities under a certain threshold until DNA replication is completed 
(Paper I). 
Interestingly, in parallel to an increase of pro-mitotic activities at the S/G2 transition, we observed 
a change in the localisation of Cyclin A2. Using genome-edited cell lines that express endogenous 
Cyclin A2-eYFP we were able to determine the cell cycle-dependent localisation of Cyclin A2 to 
the cytoplasm. Interestingly, despite coinciding with an increase of Cdk activity in the cell cycle 
  
we found that the cytoplasmic accumulation Cyclin A2 is modulated by p21 and the presence 
rather than activity of Cdk1. These findings suggest that complex formation and interaction with 
Cdk inhibitor proteins (CKI) might regulate Cyclin A2 localisation throughout the cell cycle 
(Paper IV). Despite not having uncovered a role for cytoplasmic Cyclin A2, we hypothesise that 
the cell cycle-dependent localisation of cyclins may be an important step to regulate Cdk activity.  
In order to understand how cells modulate Cdk activity upon DNA damage we made use of 
endogenously tagged cell lines expressing Cyclin B1-eYFP. We found that upon DNA damage 
cells continue to accumulate Cyclin B1 until reaching levels that are normally present in G2 
phase. At this point, cells translocate Cyclin B1 to the nucleus in a p21 and p53- dependent 
manner where it is degraded by APC/CCdh1. We identified nuclear translocation and degradation 
of Cyclin B1 as a restriction point in the cell cycle when cells irreversibly exit the cell cycle and 
become senescent (Paper II).  
Senescence is regarded as an early barrier for tumorigenesis as it prevents the propagation of cells 
with damaged DNA. Our findings in Paper II suggested a link between mitotic inducers and the 
induction of senescence; therefore we decided to investigate the role of Cdk activity in terminal 
cell cycle exit. We found that upon DNA damage cells preserve low levels of Cdk activity to 
ensure that damaged cells continue to progress through the cell cycle until they reach a point 
where they can be forced into senescence. In this context, we found that Cdk activity induces p21 
expression in a p53-independent manner to promote nuclear translocation and degradation of 
Cyclin B1 and other mitotic inducers (Paper III).  
Altogether, the data presented in this thesis points towards the existence of a link between the 
mitotic entry network and the DNA damage response to modulate the activity of Cyclin-Cdk 
complexes in time and space to trigger ensure correct progression to mitosis or, when needed, to 
trigger senescence.  
 
 
 
  
LIST OF ABBREVIATIONS AND DEFINITIONS 
 
Eukaryote: cell with a nucleus, all multicellular organisms are made of eukaryotic cells.   
Cdk: Cyclin-dependent kinase: One of the main kinases that regulate cell cycle progression. 
Cks: Cyclin-dependent kinase regulatory subunit. Cks is a small protein that binds Cyclin-Cdk 
complexes. 
MPF: Maturation Promoting Factor or Mitosis Promoting Factor. MPF was the first Cyclin-Cdk 
complex discovered in Xenopus egg extracts. It was later discovered to be Cyclin B1-Cdk1.  
Mitosis entry network: term to define the complex network of proteins that regulate mitotic 
entry. Cdks and Plk1 are two of the major proteins involved in the mitotic entry network. 
DDR: DNA damage response. Term to define the network of proteins and cellular processes that 
sense DNA damage and activate effectors to generate an appropriate response to the inflicted 
damage. 
CKI: Cdk inhibitor proteins. CKIs are small proteins that inhibit Cdk activity. The family of 
CKIs includes p21, p27 and p57 among others.  
Wee1 and Myt1: Kinases that phosphorylate Cdk1 inhibiting it.  
Cdc25: Family of phosphatases that activate Cdk1 and Cdk2 by removing the phosphorylations 
introduced by Wee1 and Myt1. 
Plk1: Polo-like kinase 1. Together with Cdk, Plk1 is one of the main kinases that regulates cell 
cycle progression. Plk1 becomes essential for cell cycle progression after DNA damage. 
PP1 and PP2A: Protein phosphatase 1 or Protein phosphatase 2A. Different Serine/Threonine 
phosphatases involved in the regulation of the phosphorylation status of Cdk targets.  
Rb: Retinoblastoma protein. Family of tumour suppressors that modulates the restriction point in 
the human cell cycle by restricting the expression of E2F targets.  
E2F: family of transcription factors that promote cell cycle progression.  
B-Myb, FoxM1, NF-Y: different transcription factors that modulate the expression of cell cycle 
genes.  
  
APC/C: Anaphase Promoting Complex or Cyclosome. E3 ligase that targets cell cycle regulators 
for degradation in different phases of the cell cycle. APC/C requires an activator to recognise 
targets: Cdh1 or Cdc20 are the two activators of human APC/C. 
SCF: Skp-Cullin-F-Box-containing protein. SCF is the general name of the other family of E3 
ligases that regulate the degradation of cell cycle regulators. Similarly to APC/C, SCF E3 ligases 
require F box containing proteins to determine substrate specificity; β-TrCP is an example of F-
box protein involved in the regulation of cell cycle targets. 
RPA: Replication Protein A: it’s a protein that binds single stranded DNA preventing the 
formation of secondary structures. 
Senescence: cellular state characterised by the absence of proliferation. Senescence differs from 
G0 phase in that senescent cells irreversibly exit the cell cycle whereas cells in G0 can resume 
proliferation. 
p53: one of the most famous tumour suppressor genes and it’s popularly known as “the guardian 
of the genome” for its many roles in the DNA damage response. 
p21: member of the family of CKIs. p21 is especially important to modulate senescence.  
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1 INTRODUCTION 
 
“Omnis cellula e cellula”  
In 1855, Rudolf Virchow postulated his famous quote “Omnis cellula e cellula”, i.e. a cell comes 
from another cell, pointing already to the idea that cell proliferation is key for multicellular 
organisms 1. Cell division is indeed the basis of life development. All multicellular organisms 
come from one cell and develop to over 30 trillion cells in the case of humans 2. Cell proliferation 
lies at the basis of such achievement, and it constitutes the basis of multicellular life.  
Eukaryotic cell division is a very complex and tightly regulated process that leads to the 
generation of a daughter cell that contains the same content and genetic information as the mother 
cell. Eukaryotic cells manage to create more cells by progressing through the cell division cycle 
(hereafter referred to as cell cycle), completing a series of tasks in a given order. Originally, the 
chromosome theory postulated by Boveri and Sutton in 1904 gave importance to the events in the 
cell that modified chromosomes 3, 4. The cell cycle was therefore divided in phases according to 
chromosome behaviour. In this context, two phases are important: synthesis phase, or S phase, 
during which cells duplicate their entire genome creating a copy of each chromosome; and 
mitosis, the cell cycle phase where cells divide and segregate a copy of each chromosome into 
each of the two daughter cells generated. The phases between the completion of mitosis and 
initiation of S phase and from the end of S phase to the next mitosis were designated as Gap1 and 
Gap2 phases respectively (Figure 1 and 5). Ever since, extensive study has focused on each of the 
phases of the cell cycle, however the exact mechanisms driving progression through the cell cycle 
remain an open question.  
 
Figure 1. Schematic representation of the human cell cycle. 
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Conservation in the eukaryotic tree 
Progression through the cell cycle is a highly controlled process regulated by multitude of 
proteins, at the centre of which stands a family of Serine/Threonine heterotrimeric kinases called 
Cyclin-Cdk complexes (Figure 1). Cyclin-Cdk complexes are composed by a catalytic subunit, a 
cyclin dependent kinase (Cdk), and a regulatory subunit, a cyclin and an adaptor protein, Cks 6.  
During the 1980s, different research groups identified the Maturation Promoting Factor, MPF, as 
the regulator of mitotic progression 7. Later, further studies on MPF and cell cycle progression led 
to the identification of cyclins and Cdks as central elements of the cell cycle engine 8. Cyclins 
were first identified in sea urchin eggs as proteins translated from maternal mRNAs that are 
destroyed at each cleavage division 9. Later their discovery in other species like yeast, 
amphibians, Drosophila and human cells demonstrated the high conservation through evolution 
and the importance of cyclins and Cdks in the regulation of the cell cycle 10, 11.  
Interestingly, despite presenting slight differences in the amount of proteins involved in the 
process, the molecular mechanisms underlying the progression through the eukaryotic cell cycle 
are highly conserved across species from yeast to higher eukaryotes. Indeed, the core machinery 
of the cell cycle can be traced back to early eukaryotes 12, 13. Surprisingly, while plants seem to 
contain homologues of most of the cell cycle regulators found in animals, yeast do not, indicating 
that the last common ancestor before the bifurcation between plants and animals probably 
presented these regulators but they were lost in fungi 12. However, the conservation of cell cycle 
control mechanisms across the eukaryotic tree points towards Cyclin-Cdk complexes as an 
efficient way to control cell cycle progression and proliferation 13.  
All the work presented in this thesis has been performed in human cell lines, therefore, I will use 
the human nomenclature for the different players in the cell cycle hereinafter.   
 
The human cell cycle 
Different waves of Cdk activity are responsible for the timely phosphorylation of Cdk substrates 
to complete the different phases of the cell cycle. G1 phase is mostly driven by Cyclin D-Cdk4/6 
complexes. Upon passage through the restriction point (see below), Cyclin E-Cdk2 complexes 
initiate entry into S phase that is maintained by the action of Cyclin A2-Cdk2 complexes. After S-
phase completion Cyclin A2 and Cyclin B1 form complexes with Cdk1 to drive progression 
through G2 phase and induce mitotic entry. Finally, Cyclin B1 regulates correct progression 
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through mitosis 6. Waves of Cdk activity are, therefore, key to keep orderly progression through 
the cell cycle and to ensure that cells execute each process at a specific given time.  
Cdk activity is first initiated after commitment to the cell cycle upon mitogenic stimulation. This 
point in the cell cycle is known as the restriction point and marks the cell’s commitment to 
progress through the cell cycle 14. In this context, cells respond to extracellular mitogens and start 
expressing increasing levels of Cyclin D. Once Cyclin D has reached a certain threshold it forms 
complexes with Cdk4/6 that can phosphorylate the Retinoblastoma proteins (Rb). Rb is a family 
of tumour suppressor proteins that put a break on the cell cycle by preventing progression from 
G1 to S phase 15. During G1 phase, Rb proteins associate with different members of the E2F 
family of transcription factors to block the expression of cell cycle inducers. Upon 
phosphorylation by Cyclin D-Cdk4/6, Rb releases E2F leading to the synthesis of several mitotic 
inducers. One of the targets of active E2F are S phase cyclins, Cyclin E and Cyclin A. Cyclin E 
forms complexes with Cdk2, which further phosphorylates Rb leading to its full inhibition and 
releasing the break on E2F-dependent transcription (Figure 2) 16, 17. This marks the initiation of 
DNA replication and is accompanied by an increase in the transcription of other E2F targets with 
important roles in S phase progression like Cyclin A2 and Cdc25A 18-21. 
 
 
Figure 2. Schematic representation of commitment to the cell cycle in response to mitogens by the action of 
Cyclin D-Cdk4/6 leading to E2F-dependent transcription of Cyclin E and Cyclin A. 
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The succession of cyclins leads to a controlled increase of Cdk activity over time providing 
directionality and robustness to cell cycle progression. In this context, every cyclin leads to the 
expression of the next one and subsequently the associated Cdk activity (Figure 3).  
 
 
 
Figure 3. Schematic representation of cyclin dynamics in the human cell cycle and in relation  
to general Cdk activity. 
 
The discovery that Cdc2 (Cdk homologue in fission yeast) promotes both S phase and mitotic 
entry led to the idea of a quantitative model for Cdk activity control 22. In 1996 Stern and Nurse 
proposed a model, which suggests that in yeast different levels of Cdk activity regulate the order 
of events in the cell cycle 23, 24. Therefore, it is not a qualitative difference in Cyclin-Cdk 
complexes that regulates the different phases of the cell cycle but rather the levels of Cdk activity. 
In a nutshell, low levels of Cdk activity are needed to trigger and maintain S phase whereas high 
levels promote mitotic entry. 
Despite being a model proposed for yeast, studies conducted in other systems exhibit a similar 
behaviour. In particular, it has been shown that the G1/S transition in mammalian cells depends 
on a balance between the degradation of p27 (a small Cdk inhibitory protein) and the 
accumulation of Cyclins E and A to form complexes with Cdk2. Therefore, once sufficient p27 is 
degraded, enough Cdk2 activity can build up to trigger S phase initiation 25, 26. In line, 
Pomerening and colleagues demonstrated that expression of a constitutively active form of Cdk1 
in mammalian cells leads to the shortening of G1 and S phases which translates into failed 
progression through mitosis, indicating that low levels of Cdk activity are needed for normal 
progression through S phase 27. Cyclins are synthesised during S phase, in particular the increase 
of Cyclin A2 and consequently of Cdk2 activity during S phase has been shown to lead to the 
  7 
disassembly of pre-replicative complexes thus limiting the use of origins to just once per cell 
cycle 28. However, Cyclin A2-Cdk2 and Cyclin E-Cdk2 activity are kept under a certain threshold 
to prevent premature phosphorylation of mitotic targets as well as DNA damage, indicating that 
moderate levels are required to maintain S phase (see section “The DNA damage response in the 
unperturbed cell cycle: a role in S phase”). In late S phase, Cyclin A2 induces FoxM-dependent 
Cyclin B1 transcription initiating the transition towards G2 phase 29. At this point, Cyclin A2-
dependent appearance of Cyclin B1-Cdk1 complexes leads to an increase in Cdk activity bringing 
the system to the high Cdk activity that triggers the phosphorylation of a multitude of targets 
orchestrating the way to mitosis 30-32.  
The quantitative model for Cdk activity proposes that cell cycle progression is mediated by 
increasing Cdk levels, suggesting that cyclin specificity is not essential. Indeed, different cyclins 
have been shown to be able to replace each other in Xenopus or mammalian systems indicating a 
certain degree of redundancy in the mechanisms of control 33-36. In addition, two large-scale mass 
spectrometry studies directed to investigate cell-cycle dependent phosphorylations identified a 
vast number of phosphorylated targets in mitosis in contrast to interphase. Moreover, they 
observed that many targets are phosphorylated on multiple sites suggesting that phosphorylation 
is more efficient during mitosis than in interphase 37-39. Together, these studies support the basis 
of the quantitative model of Cdk activity with low Cdk activity during S phase and high during 
mitosis.  
In parallel, a qualitative model has also been suggested which in combination with the 
quantitative model, gives cyclins a role in modulating the specificity of Cdks towards different 
targets 40. In line with this, Loog and Morgan showed that, in yeast, S phase cyclins have higher 
affinity towards certain S phase-specific targets than M-Cyclins although some substrates are 
equally recognised by both cyclins 41. A more recent study reported that cyclins can influence 
substrate specificity, therefore highlighting the importance of individual cyclins in the normal 
progression of the cell cycle 42. Furthermore, Cdk2 has been shown to be a non-redundant 
regulator of the G1/S transition suggesting that the variety of cyclins and Cdks in mammalian 
systems might provide the required elements to separate processes in space and time to fine-tune 
cell cycle progression 43, 44.  
Overall, cyclins accumulate during the cell cycle reaching a maximum at mitosis when they are 
efficiently degraded. This step is crucial to bring the levels of Cdk activity back to a basal level 
that restarts the cycle. However, Spencer and colleagues recently showed that the levels of p21, a 
small Cdk inhibitor (CKI) determine cell fate after mitosis. By these means cells either commit to 
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the next cell cycle and start building up Cdk2 activity directly after mitosis, or remain 
uncommitted and Cdk levels remain low 45.  
 
The cell cycle control mechanism 
The beauty of the orchestrated progression through the cell cycle is the result of a very tight 
coordination of a complex network of kinases and phosphatases. Due to the scope of this thesis, I 
will focus on the mechanism of control of Cdk1 and Cdk2 activities mostly during G2 phase. The 
different layers of control that ensure timely activation of Cdk activity are summarised below.   
 
Cyclin availability 
Cdks alone are not active; they require the binding of a cyclin to become activated 46. Therefore, 
the presence or rather absence of cyclins poses a first level of regulation on Cdk activity. A 
transcriptional program driven by E2F, FoxM, NF-Y and B-Myb ensure the timely transcription 
of specific mRNAs leading to the orderly expression of cyclins in a sequence starting from Cyclin 
E followed by Cyclin A and last Cyclin B 20, 29, 47, 48. Together with transcription, E3 ligases are 
essential regulatory elements of the cell cycle to timely degrade cyclins. Different E3 ligases are 
responsible for the degradation of cyclins throughout the cell cycle. During early G1 phase, 
APC/CCdh1 is responsible to prevent premature cyclin accumulation and to maintain a basal low 
level of pro-mitotic inducing activities 49. During S and G2 phases, the combined action of SCF 
E3 ligases and APC/CCdc20 maintain a controlled level of cyclins 50, 51. Last, APC/C targets 
Cyclins A and B during mitosis. In detail, APC/CCdc20 times the degradation of Cyclin A at 
prometaphase while APC/CCdh1 is responsible for the degradation of Cyclin B and securin at 
anaphase to ensure correct chromosome segregation 52-54.  
Interestingly, both the transcription factors and E3 ligases that control Cdk activity are direct 
targets of Cyclin-Cdk complexes, thus introducing a first feedback loop in the regulatory 
mechanisms (see below). 
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Post-translational modifications 
A crucial regulatory step of Cyclin-Cdk complexes activity comes from the balanced action of 
phosphatases and kinases. Upon binding of a cyclin, the conformation of Cdk changes exposing 
its T loop. At this stage, Cdk-activating Kinase (CAK) phosphorylates Cdk1 and Cdk2 at a 
conserved threonine residue (T161 and T160, respectively) (Figure 4 and 55, 56). 
 
Figure 4. Schematic representation of structural activation of Cyc-Cdk complexes by phosphorylation  
of the T loop by CAK. 
 
However, this represents only a structural activation. Upon phosphorylation by CAK, Cyclin-Cdk 
complexes are phosphorylated and inhibited by two kinases: Wee1 and Myt1. These two kinases 
phosphorylate Cyclin-Cdk complexes at Tyr15 and Thr14 leading to the inhibition of Cdk activity 
57, 58. These inhibitory phosphorylations can be removed by the action of Cdc25, a family of 
phosphatases with three members, Cdc25A, B and C, each of which play different roles to 
regulate Cdk activity at different points in the cell cycle (Figure 5 and 59, 60).   
 
 
Figure 5. Representation of Cyclin-Cdk activation by the balanced action of Wee1/Myt1 and Cdc25. 
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Feedback loops 
The full activation of Cyclin-Cdk complexes therefore requires (1) a cyclin and (2) the balanced 
action of Wee1/Myt1 and Cdc25s. However, additional proteins introduce several feedback loops 
in the system and make the activation of Cyclin-Cdk complexes robust and switch-like in 
behaviour. In this context, active Cdk1 phosphorylates Wee1 and Cdc25s (Figure 6). 
Phosphorylation on Wee1 leads to its degradation in a SCFβTrCP-dependent manner consequently 
resulting in a decrease in the inhibitory force on Cdk1 activity 61-63. On the other hand, Cdk1-
dependent phosphorylation of Cdc25s leads to their stabilisation, thus translating into a further 
increase in Cdk1 activity 64. These events introduce a negative and a positive feedback loop 
respectively that leads to a rapid amplification of Cdk activity once the first activation is 
triggered. Interestingly, Cdk1-dependent phosphorylation on Wee1 and Cdc25s involves 
ultrasensitive multisite phosphorylation, meaning that phosphorylation is rather inefficient at low 
levels of Cdk activity but increases dramatically in a non-linear manner once Cdk activity starts 
increasing 65, 66. This switch-like behaviour of Cdk activity provides directionality and 
irreversibility to cell cycle transitions 30, 67.  
As mentioned above, in addition to a cyclin and a Cdk, Cyclin-Cdk complexes include a small 
adaptor protein called Cks. Although Cks has been found to have essential roles in cell cycle 
progression its specific function is not fully clear 68. However, a recent study revealed that Cks is 
able to bind phosphoryalated targets in a sequence-dependent manner and direct Cyclin-Cdk 
complexes to facilitate multisite phosphorylation 69. In this context, Cks proves to be an essential 
element to regulate the switch-like behaviour of Cdk activity.  
Additional proteins are involved in the feedback loops that activate Cdk complexes. Plk1, for 
example, phosphorylates Cdc25 activating it, and Wee1, modifying it in a way that leads to its 
degradation to further promote Cdk activation 70. On the other hand, several phosphatases exist in 
cells to oppose Cdk activity by dephosphorylating Cdk targets. Phosphatase activity is essential to 
ensure correct progression through the cell cycle, and growing evidence suggests that 
phosphatases are highly controlled to modulate the phosphorylation status of different substrates 
in the cell cycle 71-73. Perhaps the clearest example of phosphatase importance for cell cycle 
control comes in at the end of mitosis, when timely dephosphorylation of Cdk targets by PP1 and 
PP2A ensures correct completion of mitosis 74, 75. 
In the control of interphase, the PP2A family of phosphatases is able to dephosphorylate Cdc25 
and Wee1 thus reverting the phosphorylations carried out by Cdk1. Recently, another kinase has 
come into the feedback loops game. MASTL (or Greatwall, Gwl) in collaboration with two small 
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regulators Arpp19/Endosulfin-α, phosphorylates and inhibits PP2A at the G2/M transition to 
boost Cdk activity and ensure timely activation of Cyclin-Cdk complexes prior to mitotic entry. 
This combination of Gwl, and Cdks has been recently proposed as a more complete description of 
MPF 74, 76-80. Interestingly, a common factor in the feedback loops is that elements in the system 
are direct or indirect targets of Cdk. This provides Cdk the capacity to regulate its own activity 
and subsequently set phase transitions in a robust and irreversible manner.   
 
 
 
Figure 6. Representation of the feedback loops that modulate Cdk activity. Cdc25s lead to the activation of Cyc-
Cdk complexes which promote their own activity by Plk1-dependent Wee1 degradation, Cdc25 further 
activation and inhibition of PP2A by the MASTL-Arpp19/Ensa pathway. 
 
Spatial regulation 
Cyclins, Cdks and the different elements of cell cycle control are restricted to distinct cellular 
compartments, therefore limiting their activities to a certain extent by the localisation of its 
components. The clearest example of regulation of activity from a spatial perspective comes from 
cyclins.  
Cyclins E and A are mostly nuclear whereas Cyclin B is mostly cytoplasmic. However, all three 
cyclins have been shown to shuttle between the nucleus and cytoplasm 81, 82. Interestingly, the 
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mechanisms by which they do so are distinct between cyclins. Cyclin E contains a nuclear 
localisation signal (NLS) in its N-terminus that is required for its transport into the nucleus via 
interaction with Importin-α/β 83, 84. Similarly, Cyclin B1 has been found to contain a non-typical 
NES at its N-terminus named cytoplasmic retention signal (CRS) that favours its localisation in 
the cytoplasm by the interaction with Exportin1/Crm1 82, 85, 86. In this sense, both Cyclins E and B 
use the Importin/Exportin system to shuttle between nucleus and cytoplasm. In contrast, Cyclin 
A, which does not contain an NLS, depends on the binding to other proteins to mediate its 
transport. Maridor and colleagues demonstrated that the capacity of Cyclin A to bind its partner 
Cdk2 determined the ability to localise to the nucleus 87. Additional studies reported that proteins 
like p21 or p107 could interact with Cyclin A to potentially modulate its localisation (discussed in 
88). Further, a screen to identify Cyclin A2 interacting partners revealed SCAPER, an ER-
associated protein that directs Cyclin A2 localisation to the cytoplasm 89. However the exact 
mechanisms that regulate the localisation of Cyclin A2 remain unclear.   
In addition to cyclins, Cdc25s also shuttle between the nucleus and cytoplasm through an NES 
and an NLS present in their sequences thus providing tools for local activation of Cyclin-Cdk 
complexes 90, 91. In addition, Cdc25B localisation is also regulated in response to DNA damage, 
when it becomes cytoplasmic to prevent nuclear Cyclin-Cdk activity, highlighting the importance 
of spatial regulation of protein activity 92. Similarly Plk1 contributes to the spatial control of Cdk1 
regulators. Plk1 can phosphorylate the inhibitory kinase Myt1 that resides in the cytoplasm thus 
promoting the local activation of Cyclin-Cdk complexes. Simultaneously it phosphorylates 
Cyclin B1 and Cdc25B promoting their transport into the nucleus prior to mitotic entry 93-97.   
The dynamic localisation of different cell cycle regulators suggests that spatial control of cell 
cycle regulators is required to limit certain activities at specific locations in the cell. By these 
means, cells are able to modulate pro-mitotic inducing activities in a more refined manner 98, 99. 
Cyclin B1, for example, can be activated at the centrosome where the restricted localisation might 
provide a concentration-dependent mechanism to activate Cyclin B1-Cdk1 complexes 97, 100. On 
the other hand, Cyclin B1-Cdk1 promotes its own translocation into the nucleus prior to mitotic 
entry thus introducing a spatial feedback loop to the network that activates MPF 101. Similarly, 
Plk1 has been shown to promote its localisation to kinetochores during mitosis to ensure correct 
chromosome segregation and successful completion of mitosis 102.  
Altogether, the discovery of spatial feedback loops during G2 highlights the importance of 
control of Cdk activity at different locations in the cell to ensure successful progression through 
the cell cycle.  
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Cyclin A2 and B1 in particular 
Both Cyclin A and Cyclin B are responsible for the progression through G2 phase and to promote 
mitosis. Despite being similar in structure and presenting significant overlap during the cell cycle 
their functions are largely different and represent the core components of cell cycle machinery 6, 
103. Both cyclins were identified at a similar time in yeast, sea urchin and different cell lines and 
several studies determined their mRNA and protein levels, showing that Cyclin A starts to 
accumulate at the beginning of S phase whereas Cyclin B first appears at the end of S phase. 
These early studies on cyclins also characterised the differences in their localisation and 
degradation showing that Cyclin A is predominantly nuclear and degraded earlier than Cyclin B 
which is mostly cytoplasmic 104-106. 
There are two type-A cyclins in higher eukaryotes: Cyclin A1 and Cyclin A2. Cyclin A1 has a 
role during embryonic development and in the germ line, however its absence only leads to male 
infertility indicating that Cyclin A1 is not an essential cyclin. On the other hand, Cyclin A2, 
which is expressed in somatic cells, is essential for the cell cycle and its deficiency leads to early 
embryonic lethality 107. A recent study revisited this concept and demonstrated that cells derived 
from conditional Cyclin A2-/- mice maintain Cyclin E expression throughout S phase to preserve 
relatively normal progression through the cell cycle. These observations suggest that both Cyclin 
E and A may have redundant functions in certain cell types 35.  
Cyclin A2 is a rather unusual cyclin because it is expressed from S phase to mitosis and can form 
complexes with both Cdk1 and Cdk2. These unique features give Cyclin A2 the possibility to 
regulate processes in S and G2 phases and mitosis 108, 109.  
During S phase, Cyclin A2 associates with actively replicating DNA and promotes replication by 
associating and phosphorylating DNA polymerases α and δ and crucial elements for DNA 
replication like Proliferating Cell Nuclear Antigen (PCNA) 110-113. It has also been reported that 
Cyclin A2-Cdk1 complexes may have an important role in regulating the firing of late origins of 
replication 114. Later in S phase, Cyclin A2 is responsible for providing directionality to S phase 
and preventing re-replication by promoting the cytoplasmic localisation of Cdc6 which is needed 
for initiation of DNA replication 115. At the same time, Cyclin A2-Cdk activity has been shown to 
inhibit the APC/C regulatory subunit Cdh1 preventing cyclin degradation and resulting in E2F-
dependent Cyclin B accumulation during the last stages of S phase 51. Last, aside from having key 
nuclear functions during S phase, Cyclin A2-Cdk2 activity has also been reported to be required 
for centrosome duplication 116.  
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In G2 phase, Cyclin A2 has been shown to phosphorylate and activate the transcription factor 
FoxM1, which leads to the transcription of targets important for G2/M progression, such as 
Cyclin B1, Cdc25 or Plk1 29, 47, 117. Later at the G2/M transition, Cyclin A2-dependent activities 
coordinate centrosomal and nuclear events acting upstream of Cyclin B1-Cdk1 complexes in a 
rate-limiting manner 109, 118. In this context, Cyclin A2-Cdk activity is needed to promote the 
activation of Cyclin B1-Cdk1 complexes possibly by phosphorylating and inactivating Wee1 and 
regulating Cdc25B and Cdc25C. Therefore, Cyclin A2 could constitute a trigger to tip the balance 
of Cdk versus Wee1 towards active Cdk1 119, 120. At mitotic entry, Cyclin A2-Cdk is needed to 
promote CycB1-Cdk1 nuclear translocation, chromosome condensation and nuclear envelope 
breakdown (NEBD) 121, 122. Additionally, a recent report showed that Cyclin A2 is also important 
to promote kinetochore microtubule detachment to ensure correct chromosome segregation 123.  
Unlike Cyclin A, Cyclin B expression is restricted to G2 phase; it has been extensively studied 
due to its implications in the correct execution of mitosis. There are three types of B cyclins in 
higher eukaryotes: Cyclin B1, B2 and B3. Cyclin B1 and B2 are expressed in somatic cells 
whereas Cyclin B3 is restricted to embryonic development and the germ line. Cyclin B1 is the 
main B-type cyclin and it is the one that performs most of the mitotic functions and similar to 
Cyclin A2, its deficiency leads to early embryonic lethality 124. Despite shuttling between the 
nucleus and cytoplasm, Cyclin B1 is predominantly cytoplasmic while Cyclin B2 localisation is 
more limited to certain subcellular structures like centrioles, centrosomes or the Golgi apparatus 
125-127. Cyclin B1 first appears at the beginning of G2 phase and its levels rapidly increase 
reaching a maximum at mitosis when it is degraded at the metaphase to anaphase transition by 
APC/CCdh1 (Paper I and 6, 29). Cyclins B1 and B2 form complexes with Cdk1 at the beginning of 
G2 phase, which become rapidly activated by the action of several feedback loops as described 
above. Cyclin B-Cdk1 complexes accumulate in the cytoplasm during G2 and a small fraction 
localises in the centrosomes from the moment of centrosome duplication 128. Accordingly, Cyclin 
B2 has been recently shown to be required for the initiation of centrosome separation 127 
The ultimate function of CycB1-Cdk1 complexes is to prepare the cell for mitotic entry and to 
ensure correct progression through mitosis. Cyclin B1-Cdk1 complexes are responsible for the 
separation of centrosomes to the opposite poles of the cell, to reorganise the microtubule network 
to form the mitotic spindle, and to activate a myriad of targets that will regulate specific processes 
in mitosis 100, 129, 130. One of the main functions is to promote the full activation of APC/C and 
subsequently its own degradation as well as that of other targets important for chromosome 
segregation 131. This step is crucial to reset the system to a basal level of mitotic activities that 
allow entry and progression through a new cycle.  
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The DNA damage response 
Our genomes are constantly exposed to agents that can damage the DNA. In fact, each cell in the 
organism experiences an average of 105 DNA breaks per day 132, 133.   
There are a large variety of agents that can damage DNA, both exogenous and endogenous. One 
of the most common exogenous physical genotoxic agents is ultraviolet radiation (UV), which 
usually comes from sunlight. UV radiation causes covalent cross-linking of pyrimidine bases 
usually leading to the appearance of thymidine dimers that interfere with DNA replication 
resulting in breaks in the DNA. Similarly, ionising radiation (IR) originating from cosmic rays or 
medical treatments like X-rays can induce single and double strand breaks 134. Other examples of 
exogenous DNA damaging agents fall into the category of chemicals, like the many components 
of cigarette smoke 135. In the class of chemical genotoxic agents, chemotherapy drugs cause DNA 
strand breaks by different means like oxidative damage, cross-linking bases within the same or 
different DNA strands, or by inhibiting different enzymes like topoisomerases. In this class we 
find agents such as camptothecin or etoposide, commonly used drugs both in therapy and 
research 136-138.  
In addition to exogenous DNA damaging agents, DNA molecules are constantly exposed to 
endogenous sources of damage. Here, distinct mechanisms can be highlighted. On the one hand, 
DNA molecules are exposed to reactions in the cell that produce reactive oxygen species (ROS) 
or byproducts resulting from cell metabolism which can lead to hydrolysis of bases or DNA 
oxidation, and eventually lead to DNA damage 139, 140.  
On the other hand, the processes of DNA replication and transcription can give rise to Double 
Strand Breaks (DBSs). Arrested replication forks, active transcription and collision between 
polymerases transcribing and replicating DNA are clear examples of situations that can cause 
DNA damage 141-143.  
Regardless of the source of DNA damage, any insults to the DNA can cause the appearance and 
accumulation of mutations, which can eventually lead to the loss of information contained in the 
genome. Therefore, maintenance of genome integrity is crucial to ensure successful generation of 
daughter cells. Repair mechanisms and checkpoints have evolved in eukaryotic organisms to 
ensure that cells repair the lesions in the DNA before they progress into mitosis.  
Cells activate different DNA repair mechanisms depending on the type of damage they encounter. 
The first consideration is the extent of the damage. Single strand breaks or damage that affects 
only one of the two DNA strands can be repaired by one of the following mechanisms: 
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-­‐ Base Excision Repair (BER): this is the mechanism of choice to repair nucleotides with 
small alterations in their structure or to introduce a missing nucleotide. Cells detect the 
wrong nucleotide, excise it and use the undamaged DNA strand to correctly introduce the 
missing nucleotide. BER repairs minor lesions, e.g. alkylations or deaminations of bases 
144.  
-­‐ Nucleotide Excision Repair (NER): this pathway detects bulky nucleotides like 
thymidine dimers caused by UV radiation. Upon detection, cells excise 12-30 nucleotides 
surrounding the region where the modified nucleotide is detected, and use the undamaged 
strand as template to repair the DNA 145. 
-­‐ Mismatch repair: this mechanism identifies mismatched pairs of nucleotides, usually 
during DNA replication 146.  
DSBs, on the other hand, represent the most deleterious type of damage and require different 
mechanisms of repair due to the lack of the undamaged strand to be used as a template. This type 
of lesions usually arises from physical and chemical genotoxic agents like IR or different drug 
treatments. Several pathways exist to repair DSBs: 
-­‐ Non-homologous end joining (c-NHEJ): this repair mechanism simply joins the two 
ends of the broken DNA strand. This mechanism can lead to the loss of nucleotides, 
which makes NHEJ a mutation-prone repair pathway. However it provides a rapid 
response to DSBs thus protecting genome integrity 147. 
-­‐  Homologous recombination (HR): perhaps the most complex, yet accurate repair 
pathway that cells possess. HR is based on the use of the sister chromatid or homologous 
chromosome to repair the DSB. In this case, cells resect the ends of the DNA strand 
surrounding the break and introduce the missing nucleotides using the sister chromatid or 
homologous chromosome as a template. Despite being a more accurate repair 
mechanism, the use of the homologous chromosome can lead to the loss of 
heterozygosity in a gene. This pathway is carried out during S and G2 phases due to its 
requirement for a DNA template to drive DNA repair 148.  
-­‐ Alternative non-homologous end joining (alt-EJ): This pathway was first identified as 
a back up mechanism for c-NHEJ however growing evidence suggests that this pathway 
is an independent mechanism 149. Alt-EJ depends on DSB resection like HR and relies on 
the detection of microhomology domains to repair the DNA lesion. Contrary to HR, alt-
EJ is a mutagenic repair pathway and can lead to chromosome translocations and 
mutagenic rearrangements due to its preference to ligate DSBs in different chromosomes 
150, 151.  
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The phase during the cell cycle when a cell experiences DNA damage largely affects the repair 
pathway used. In general, the rapid kinetics of c-NHEJ make it a pathway of choice throughout 
the whole cell cycle, although it dominates in G1 phase due to the lack of a DNA template to use 
for the repair. On the other hand, DSB resection-dependent repair pathways are more 
predominant during S and G2 phases as Cdk activity is needed for efficient DSB resection. 
Interestingly, it has been recently shown that despite being present during G2 phase, HR occurs 
mainly in S phase while NHEJ mediates repair throughout the cell cycle 152.  
Minor lesions on the DNA can usually be repaired shortly after they occur. This form of repair, 
usually mediated by BER or NER, does not trigger the activation of the DNA damage checkpoint 
and is repaired quickly. However, when cells experience extensive damage that requires longer 
time to be repaired cells initiate and establish a DNA damage checkpoint. The aim of the 
checkpoint is to slow down cell cycle progression to prevent mitotic entry of cells with damaged 
DNA and to provide time to repair DNA damage.  
Upon DNA damage cells possess a selection of PI3-kinase-like kinases that trigger the activation 
of a downstream cascade eventually leading to a cell cycle arrest. The MRN complex (composed 
by Mre11, Rad50 and NBS1) and the Ku complex (composed by Ku70 and Ku80) recruit and 
activate three different kinases: the kinase Ataxia Telangectasia mutated (ATM), the Ataxia 
Telangectasia and Rad3-related kinase (ATR) and DNA-PK 153, 154. While ATM and DNA-PK 
respond rapidly to DSBs, ATR is recruited mostly to RPA-coated ssDNA, either coming from a 
minor lesion in itself or as a consequence of a DSB resection, placing ATR between the DDR and 
the control of DNA replication (Figure 7 and 155). 
 
 
Figure 7. Schematic representation of the recruitment of ATM, ATR and DNA-PK,  
the three PI3-like kinases in the DDR 
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Once activated, ATM, ATR and DNA-PK phosphorylate histone H2AX at Ser139, which serves 
as a platform for the recruitment of repair factors to the site of damage. Therefore, appearance of 
γ-H2AX marks the establishment of the DNA damage response (DDR) 156, 157. Other than histone 
H2AX, ATM and ATR phosphorylate the downstream targets Chk1 and Chk2, which in turn 
phosphorylate and target Cdc25A for degradation, and activate Wee1 leading to an increase on 
inhibitory phosphorylations on Cdk1 158-160. In parallel, ATM/ATR-dependent p38 activation 
leads to the phosphorylation and activation of MapKap2 (MK2), which targets Cdc25s for 
degradation contributing to the cell cycle arrest 161, 162. 
These steps are crucial to induce a temporal and reversible arrest of cell cycle progression by 
negatively regulating the activators of Cdk activity. However, in addition to the rapid response 
elicited by ATM/ATR and Chk1/2, there are two long-term mechanisms to ensure the 
maintenance of the DNA damage checkpoint. First, the activation of the DDR kinases leads to the 
phosphorylation and stabilisation of p53 163. This process initiates the p53-dependent transcription 
program that eventually leads to the repression of several mitotic inducers like Plk1, Cyclin B1 
and Cdc25B 164-166. Second, p53 induces the expression of p21, which inhibits Cdk activity 
therefore strengthening the cell cycle arrest 167-170. Last, in parallel to the nuclear checkpoint 
pathway, p38/MK2 localises to the cytoplasm where it mediates a late response with long-lasting 
effects. MK2 stabilises certain mRNAs and establishes a feedback loop to maintain p38 
expression and subsequently the cytoplasmic component of the DNA damage checkpoint (Figure 
8 and 171).  
 
Figure 8. Schematic representation of the downstream targets of ATM and ATR to establish the DNA damage 
checkpoint. ATM and ATR activate Chk1/2 to downregulate Cdc25A and activate Wee1 to inhibit Cdk activity. 
In parallel the p53-dependent transcriptional program blocks transcription of cell cycle regulators and promotes 
expression of p21 that further inhibits Cdk activity. 
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Other than ultimately promoting a cell cycle arrest, ATM has also been shown to play a role in 
chromatin status upon DNA damage. In this context, ATM not only acts at a local level but it also 
induces a general relaxation of chromatin in a Kap1-dependent manner 172. In line with these 
findings, our lab recently showed that the spread of ATM signal through the nucleus serves as a 
timer that restricts pro-mitotic activities during a DDR until DNA repair is completed 173.  
Altogether, the combined action of ATM and ATR is essential to establish and maintain the DNA 
damage checkpoint that restricts mitosis-inducing activities and promotes repair factors.  
 
The DNA damage response in the unperturbed cell cycle: a role in S phase  
Despite having a major function to preserve genome integrity upon DNA damage, ATR and 
Chk1 also become activated during normal S phase progression. In this context, ATR associates 
with chromatin in a replication-dependent manner suggesting that ATR might be an element of 
the replication apparatus 174, 175. Indeed, the role of the ATR-Chk1 pathway is well established as 
a way to control excessive origin firing during replication 176, 177. Additionally, the checkpoint 
adaptor protein Claspin, needed for ATR-dependent Chk1 activation, has been shown to regulate 
the rate of fork progression during normal S phase 178, 179. Furthermore, lack or inhibition of ATR 
or Chk1 leads to chromosome breaks and DNA damage caused by a premature activation of 
Cyclin A2-Cdk2 114, 180-182. Chk1 phosphorylates and inhibits Cdc25A during S phase to maintain 
Cdk2 activity below a certain threshold during DNA replication (Figure 9 and 183).  
 
 
 
Figure 9. Activation of ATR/Chk1 during normal progression through S phase to control the levels of Cdc25A 
and subsequently Cyclin A2-Cdk2 activity. 
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At the late stages of S phase, Cyclin A2-Cdk has been shown to inhibit Chk1 and regulate claspin 
therefore relieving the inhibition on Cdk activity during DNA replication 184, 185. However, a tight 
control of Cdk activity is essential, since unscheduled overexpression of Cdc25s in S phase leads 
to DNA damage due to an impairment in replication fork progression 186, 187. This link between 
ATR/Chk1 and Cdc25A has been recently confirmed highlighting its importance for personalised 
cancer treatments 188.   
Altogether these findings highlight the importance of the delicate balance between the ATR-Chk1 
pathway and Cdk activity during S phase to ensure correct DNA replication and prevent 
accumulation of mutations.  
 
Cell fate after DNA damage 
DNA damage can potentially lead to genomic instability and propagation of mutations. Therefore, 
after detecting a lesion in the DNA a cell must assess the extent of the damage and respond to it, 
either to repair the DNA or initiate apoptosis 189. Indeed, the DDR targets and promotes the 
activation of both repair mechanisms and apoptotic inducers depending on the extent of DNA 
damage 190, 191. However, other than cell death, cells can face several different fates upon DNA 
damage.   
 
Recovery from a DNA damage induced cell cycle arrest 
The ultimate aim of the DNA damage checkpoint is to prevent progression of cells with damaged 
DNA into mitosis and to provide a time window for cells to repair the inflicted damage. The 
process of checkpoint recovery requires the silencing of the checkpoint proteins as well as the 
new synthesis and activation of pro-mitotic activities to resume cell cycle progression. The first 
step to recovery is to reverse the phosphorylations carried out by ATM and ATR. The main 
phosphatases that revert the action of the DDR kinases are Wip1 and PP2, which remove 
phosphorylations on H2AX, ATM, Chk2, Chk1, p53 and Mdm2 170, 192, 193. The next step towards 
cell cycle resumption requires the activation of Cdk and Plk1. As described above, the main target 
of the DNA damage checkpoint is Cdk activity, therefore the levels of Cdk activity during a DDR 
are strongly reduced but not completely abolished. In line, Alvarez-Fernandez and colleagues 
showed that the remaining Cdk activity during the DDR is enough to activate FoxM1 and 
therefore initiate the transcription of cyclins and pro-mitotic inducers 117, 194. Together with Cdk 
activity, Plk1 is targeted during a DDR, and its activity needs to accumulate for cells to resume 
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cell cycle progression. Indeed, Plk1 has been found to be essential to enter into mitosis after 
checkpoint recovery. In this context, Plk1 phosphorylates and targets Wee1 and Claspin for 
degradation by SCFβTrCP, allowing for Cdk activity to accumulate and eventually lead to mitotic 
entry 195-197. 
 
Checkpoint adaptation 
Under certain circumstances cells are able to override the DNA damage checkpoint and progress 
through mitosis with damaged DNA. This observation was first made in yeast where cells were 
able to continue to proliferate despite presenting unrepaired DNA. A mutation screen analysis 
revealed that Cdc5, the yeast homologue of Plk1, is responsible for checkpoint override. This 
scenario, named checkpoint adaptation, requires a cell cycle arrest upon DNA damage followed 
by cell cycle progression with unrepaired damage 198. Importantly, this mechanism is conserved 
in evolution and Syljuåsen and colleagues demonstrated that human cells are able to override a 
DNA damage checkpoint in a Chk1 and Plk1-dependent manner 199. Checkpoint override in 
human cells implies that cells can progress through mitosis with damaged DNA potentially giving 
rise to chromosomal breaks, which can lead to genome instability. These observations place the 
mechanisms regulating checkpoint adaptation in the spotlight as potential targets for cancer 
treatment.  
 
Terminal cell cycle exit and senescence 
As described above, upon DNA damage cells activate a checkpoint that temporally arrests the cell 
cycle, however when exposed to extensive damage the checkpoint-mediated cell cycle arrest can 
become irreversible. Cells in these conditions remain metabolically active but they do not 
proliferate; they become senescent. There are different routes to senescence depending on what 
induces the terminal cell cycle exit. First, telomere-dependent senescence is a clear example of 
how the normal progression through several rounds of division can lead to senescence. Cells rely 
on DNA polymerases to duplicate their DNA, however polymerases are not able to synthesise 
DNA ends, which translates into the loss of a few nucleotides at the ends of the DNA strands. 
Human chromosomes have telomeres at the their ends; consequently, cells lose telomeric DNA in 
every round of replication 200. Dysfunctional telomeres can trigger a strong DDR leading to the 
activation of ATM and the DNA damage checkpoint that can eventually lead to cell cycle exit 
and senescence 201, 202. Similarly, cells with extensive DNA damage or activated oncogenes can 
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undergo senescence in a p53-dependent manner 203. In particular, oncogene-induced senescence 
has been suggested to be the consequence of an accumulation of DNA damage coming from 
replication stress or damage in mitosis. Three different reports provided evidence for these 
models; di Micco and Bartkova showed that replication stress causes DNA damage that triggers 
the activation of the DDR during S phase eventually leading to induction of senescence; 
furthermore, Dikovskaya et al showed that failed mitosis is key to promote senescence 204-206. 
Senescence can therefore be regarded as a barrier to tumorigenesis as it prevents the proliferation 
of cells that carry potential deleterious mutations 207.  
The mechanism by which cells exit the cell cycle has been widely studied and shown to occur 
both in G1 and G2 phases. Focusing on G2 phase, cells with unrepaired DNA damage in G2 have 
been shown to become senescent in a p53, p21 and APC/CCdh1-dependent manner. The activation 
of this mechanism leads to the degradation of mitotic inducers leading to the loss of G2 identity 
and checkpoint recovery competence 192, 208, 209. Interestingly, growing evidence points towards a 
link between the DDR and the mitotic-inducing activities in order to regulate cell fate upon DNA 
damage (Papers II and III and 210, 211). Despite seeming a paradox, this link is likely to be a key 
regulatory step to decide whether a cell resumes cell cycle progression after DNA damage or 
permanently exits the cell cycle.  
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2 AIMS OF THE THESIS 
 
The main aim of my thesis is to understand the molecular mechanisms underlying the regulation 
of cell cycle progression. In particular, I am interested in understanding how cyclins regulate Cdk 
activity and allow timely progression through the cell cycle or induce cell cycle arrest and exit 
when it is needed. In detail, I aim: 
-­‐ To assess the dynamics of cyclins at the endogenous level and in the different phases of 
the cell cycle. 
-­‐ To understand the regulation of Cyclin-Cdk activity after DNA damage and its role in 
inducing terminal cell cycle exit.  
-­‐ To shed light on the regulation of Cyclin A2 localisation in the human cell cycle.  
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3 CHAPTER 1: HOW DO CELLS BUILD UP CDK ACTIVITY 
TO ENTER INTO MITOSIS? 
 
Cells undergo an extreme reorganisation of the intracellular structures to enter into mitosis. Part 
of this process depends on the phosphorylation of many proteins in the cell. Correct and timely 
phosphorylation of many different targets ensures that all the players are in place and ready to act 
on their substrates at a specific time and location in the cell. However, despite the extensive 
efforts to resolve the question of Cdk activation during G2, the exact details of this process 
remain elusive. Therefore, we decided to study the dynamics of Cdk activity in detail to shed light 
on the time of activation of the mitotic entry network throughout the cell cycle.  
 
When is the mitotic entry network activated?  
Cyclin B1-Cdk1 is the core of MPF, in other words, the main driver of mitotic entry. A lot of 
effort has therefore been dedicated to understand the exact mechanisms that lead to the activation 
of Cyclin B1-Cdk1 complexes. Gavet and Pines showed that Cyclin B1-Cdk1 becomes activated 
a few minutes before nuclear envelope breakdown despite being present in the cytoplasm 
throughout G2 phase 98, 99. However other reports showed evidence for the presence of active 
Cyclin B1-Cdk1 complexes earlier than a few minutes before mitosis 100. Similarly, Plk1 activity 
has been detected in the nucleus a few hours before mitotic entry suggesting that the activation of 
the mitotic entry network might be earlier than previously thought 197.  
In paper I we aimed to clarify this question using a new method based on automated 
quantification of fluorescence in single fixed cells. Our method uses fibronectin-coated 
micropatterns in order to homogenise cell shape and size and to be able to have a large number of 
individual cells with similar cell-to-matrix contacts and reduced extracellular cues that might 
affect cell cycle progression. We could show that despite being individualised, cells proliferate 
normally on micropatterns suggesting that the mechanisms of control of cell cycle progression are 
unaffected and cell cycle dynamics are maintained.  
In order to set up an automated microscopy protocol for identification of single cells we used 
Cy5-labelled fibronectin micropatterns. The recognition of the patterns by the microscope allows 
for automated identification of the position of each pattern and ensures similar illumination for 
every cell therefore reducing variability during imaging. By these means we can study several 
thousands of individual cells with similar shape and size. Furthermore, using DAPI as a nuclear 
stain and the signal of Cy5-labelled fibronectin we can easily segment images to identify 
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subcellular locations like the nucleus and cytoplasm. Additionally, the use of specific antibodies 
allows for more refined image segmentation and identification of smaller cellular structures like 
centrosomes or kinetochores. Last, the accurate quantification of background fluorescence in the 
images provides the means to correct the real signal coming from every specific antibody 
staining. 
Using our method we were able to characterise the dynamics of cyclins and Plk1 in fixed cells. 
Our results showed the expected pattern for the accumulation of cyclins (For details see paper I) 
thus confirming that our method is a powerful tool to study the dynamics of other proteins. 
Therefore, we focused our study on the quantification of post-translational modifications on 
targets of Cdk1 complexes. We found that contrary to what was previously observed, 
phosphorylation on known Cdk targets starts appearing at the S/G2 transition although at very 
low levels. These phosphorylations continue to increase throughout G2 phase and until mitosis 
when we observed a very large increase, corresponding to the time in the cell cycle when a boost 
in Cdk activity has been reported to occur 67, 98-100. Even though the targets we monitored most 
likely reflect Cyclin A2-Cdk1 activity, we provide evidence that demonstrates that a fraction of 
the phosphorylations are performed by Cyclin B1-Cdk1. In parallel to an activation of Cdk1, we 
could show that active Plk1 began to accumulate in the nucleus also at the S/G2 transition.   
Our study shows that the activation of the mitotic entry network occurs at the completion of S 
phase rather than only shortly before mitotic entry. These observations point towards a 
connection between S phase and mitosis implying that cells have a mechanism to sense the end of 
DNA replication that triggers the initiation of Cdk and Plk1 activities to start phosphorylating 
mitotic targets. Consequently, this translates into a slower yet perhaps more gradual activation of 
mitotic kinases rather than an abrupt activation prior to mitotic entry.  
 
Cytoplasmic localisation of Cyclin A2: a layer of Cdk activity regulation?  
The use of genome-targeting approaches represents a major advantage in contrast to the 
expression of fusion proteins. Despite being significantly weaker in fluorescence intensity, 
endogenously tagged proteins are controlled by the endogenous promoter and signalling thus 
allowing for the visualisation of endogenous processes in the cell as they occur. Moreover, 
expression from stably-expressed plasmids is complex since they rely on exogenous promoters 
that can lead to the overexpression of the tagged protein as well as other artefacts like 
mislocalisation or differences in regulation 212. In the case of cyclins this can be problematic since 
cyclins are known oncogenes and their overexpression may lead to dysregulation of cell cycle 
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progression and tumorigenesis 213-215. Endogenous tagging is therefore a good strategy to 
circumvent potential problems rising from variability in protein expression and regulation. 
However, careful analysis of the functionality of the tagged endogenous protein is required as 
both C- and N- terminal tagging can lead to dysfunctional proteins. 
Therefore, in order to study cyclin dynamics in live cells we established different cell lines that 
contain an EYFP tag in the endogenous locus of CCNA2 and CCNB1. Using recombinant adeno-
associated virus-mediated homologous recombination we obtained U2OS and RPE cells that 
express endogenous Cyclin A2-eYFP or Cyclin B1-eYFP (Papers I and IV and 216).  
Characterising the dynamics of Cyclin A2 during the development of paper I we observed the 
accumulation of Cyclin A2-eYFP in the cytoplasm prior to mitotic entry. Despite shuttling 
between the nucleus and cytoplasm, Cyclin A2 is predominantly nuclear 81, 106; therefore our 
observation raised the question of a potential role of Cyclin A2 in the cytoplasm. In paper IV we 
addressed the dynamics of cytoplasmic Cyclin A2 accumulation using cells expressing 
endogenous Cyclin A2-eYFP as well as untagged cells. We could show that Cyclin A2 first 
appears in the cytoplasm at the S/G2 transition and continues to accumulate throughout G2 phase 
in unperturbed cells, indicating that cytoplasmic localisation of Cyclin A2 is a cell cycle-
dependent event.  
Given that the S/G2 transition corresponds with a time in the cell cycle when changes in kinase 
activities occur, we reasoned that activities present in either S or G2 phase could regulate the 
localisation of Cyclin A2 to the cytoplasm. We identified Cdk1 as a regulator of Cyclin A2 
localisation. Interestingly, modulation of Cdk1 activity did not lead to major changes in the 
localisation of Cyclin A2. Rather, its absence after RNAi showed how a subset of cells did not 
accumulate cytoplasmic Cyclin A2 despite being in G2 phase.  
Given that Cdk1 presence does not completely explain how cells modulate Cyclin A2 localisation 
we decided to investigate if the DDR normally activated during S phase regulates Cyclin A2 
cytoplasmic accumulation. We could not identify a specific kinase activity responsible of Cyclin 
A2 localisation; however inflicting DNA damage induced a rapid loss of cytoplasmic Cyclin A2. 
Further investigation revealed that p21 or p53 knockdown prevented cytoplasmic loss of Cyclin 
A2 upon DNA damage suggesting that they could mediate the change in localisation. 
Interestingly, we found p21, but not p53, to have a role in modulating Cyclin A2 localisation in 
the unperturbed cell cycle shown by the presence of cytoplasmic Cyclin A2 in S phase in p21-/- 
cells.  
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This observation points towards a role for p21 during normal cell cycle progression, and 
importantly, it implies a decoupling between p53 and p21 suggesting that in the absence of DNA 
damage cells can induce p21 expression independently of p53 to regulate different events in the 
cell cycle. Interestingly, p53-independent p21 expression has been shown to be involved in cell 
growth and differentiation 217.  
Despite not having unveiled the role of cytoplasmic Cyclin A2, cell cycle-dependent regulation of 
cyclin localisation opens a door to a potential additional layer of regulation of Cdk activity, 
posing a spatial limitation to the activity of Cyclin A2-containing complexes.  
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4 CHAPTER 2: HOW DO CELLS REGULATE CDK 
ACTIVITY UPON DNA DAMAGE? 
 
Maintenance of genome integrity is essential to ensure the generation of identical daughter cells 
with intact chromosomes and to prevent accumulation of mutations. Therefore, upon DNA 
damage cells activate the DNA damage response and a checkpoint that temporally halts cell cycle 
progression and provides cells with time to repair DNA lesions. Consequently, one of the roles of 
the DNA damage response is to counteract Cdk activity. As described above, this is achieved by 
different means: first, with a fast response inducing the degradation of Cdc25s and second, by 
stabilisation and activation of p53, that leads to the transcriptional induction of p21 expression. 
However, low levels of Cdk activity are preserved in cells during an ongoing DNA damage 
response. It has been shown that in transformed cells, Cdk activity is able to maintain the FoxM-
dependent transcription of pro-mitotic proteins like cyclins and Plk1, and effectively to preserve 
the competence to resume cell cycle progression once DNA damage is repaired 194. However, not 
all cells remain competent to resume cell cycle progression. If the damage is too high and cells 
are not able to repair it, they may trigger apoptosis and die; alternatively they might exit the cell 
cycle and become senescent. However, how a cell is forced to exit the cell cycle is not fully 
understood. 
 
Cyclin B1 dynamics and cell fate decisions 
Degradation of mitotic inducers is one of the hallmarks of terminal cell cycle exit from G2 phase. 
In particular, Cyclins A and B form complexes with Cdk1 during G2 to regulate cell cycle 
progression, therefore studying cyclin dynamics upon DNA damage can shed light on the 
mechanisms that drive terminal cell cycle exit.  
In paper II we used endogenously tagged cell lines that express Cyclin B1-eYFP to be able to 
follow cyclin dynamics during an ongoing DNA damage response in G2 phase. In this context, 
the levels of Cyclin B1 serve both as a marker for cell cycle exit as well as a cell cycle indicator, 
with increasing levels of Cyclin B1 indicating progression through G2 phase.  
Analysis of transformed cells showed that upon damage Cyclin B1 continues to accumulate 
exceeding the levels reached during a normal progression through G2 phase and into mitosis. In 
contrast, we found that untransformed cells translocate Cyclin B1 into the nucleus and initiate its 
degradation in a p21, p53 and APC/CCdh1-dependent manner only a few hours after inflicting 
DNA damage. A long-term study of cells that had lost Cyclin B1 upon DNA damage revealed 
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that despite being alive these cells had lost the competence to recover from a DNA damage 
checkpoint-induced cell cycle arrest.  
Interestingly, a close look at single untransformed cells revealed different Cyclin B1 dynamics 
depending on the initial Cyclin B1 level before DNA damage. Cells with low Cyclin B1 
continued to accumulate Cyclin B1 up to a certain threshold before initiating translocation and 
subsequent degradation. In contrast, cells with high Cyclin B1, indicative of later stages of G2 
phase, translocated and triggered Cyclin B1 degradation almost immediately after DNA damage. 
This observation indicates that the moment of the cell cycle when a cell receives DNA damage 
determines when it initiates terminal cell cycle exit.  
Our investigation shows that nuclear translocation of Cyclin B1 and its subsequent degradation 
marks a decision point in the cell cycle. Interestingly, Cyclin B1 degradation seems to be a cell 
cycle-dependent event pointing towards Cdk activity as a regulator of terminal cell cycle exit. In 
this context, cells affected by DNA damage that are unable to repair it initiate a program 
dependent on p21, p53 and APC/C activities to degrade mitotic inducers like Cyclins A and B 
and Plk1 that leads to a loss of G2 identity and a terminal cell cycle exit from G2 phase.  
 
Keeping Cdk activity to maintain recovery competence or trigger cell cycle exit 
In paper II we identified a decision point in the cell cycle when untransformed cells degrade 
mitotic inducers and permanently exit the cell cycle from G2 phase. Interestingly the fact that 
induction of senescence upon DNA damage happened when cells reached G2 levels of certain 
mitotic inducers raised the question whether cell cycle exit correlates with cell cycle regulation. It 
has been shown previously that the DNA damage checkpoint targets Cdk activity to prevent entry 
into mitosis with unrepaired damage. However in paper III we showed that upon DNA damage 
cells maintain a certain level of Cdk activity that is needed to induce terminal cell cycle exit. Our 
study suggests that the DNA damage checkpoint and Cdk activity are interlinked. In line with our 
findings, it has been previously shown that Cdk activity is needed to maintain checkpoint 
recovery competence and to mediate repair 117, 218, 219. Interestingly, we could show that Cdk is 
involved in a feedback loop with p21 inducing its expression independently of p53. This step 
contributes to Cyclin B1 nuclear translocation and subsequent degradation therefore initiating the 
steps to induce senescence.  
In summary, Cdk activity has a decision-making role both in unperturbed progression through the 
cell cycle to induce mitotic entry and upon DNA damage to induce entry into senescence when 
damage cannot be repaired. 
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5 CONCLUSIONS 
 
The general aim of this thesis was to explore cyclin dynamics and the regulation of Cyclin-Cdk 
activity both in the unperturbed cell cycle and upon DNA damage.  
In order to study cyclin dynamics we established a quantitative immunofluorescence method to 
analyse protein levels and post-translational modifications in single cells (Paper I). We showed 
the levels of cyclins E, A and B in an unperturbed cell cycle. In addition we found that the levels 
of Cdk target phosphorylation started to increase at the transition between S and G2 phases. 
Using our newly established method we were able to demonstrate that mitosis-inducing activities 
start earlier than what was previously shown. Therefore, our study can serve as a starting point for 
a revision of the current model of Cdk activation to explain cell cycle progression.  
In parallel, using genome-targeting approaches we established different cell lines that express the 
ORF for EYFP in the CCNA2 and CCNB1 loci. Using these cell lines we were able to confirm 
and validate the kinetics of cyclin accumulation during the unperturbed cell cycle (Paper I). 
Furthermore, the comprehensive analysis of single cells expressing Cyclin A2-eYFP revealed the 
cell cycle-dependent localisation of Cyclin A2 to the cytoplasm (Paper IV). In particular we 
found that Cyclin A2 changes its localisation from being only nuclear to both nuclear and 
cytoplasm at the S/G2 transition and throughout G2 phase. Despite having identified an increase 
in Cdk and Plk1 activities at the S/G2 transition (Paper I), these do not seem to mediate the 
change of Cyclin A2 localisation. Rather, our findings suggest that a change in binding partner 
might mediate Cyclin A2 localisation to the cytoplasm. Surprisingly, modulating certain elements 
of the DNA damage response had the most evident effect on Cyclin A2 localisation. In particular, 
the absence of p21 led to a marked increase in the number of cells expressing cytoplasmic Cyclin 
A2 in S phase in contrast to WT cells which express cytoplasmic Cyclin A2 exclusively during 
G2 phase. Together, our results suggest that both p21 and the presence of Cdk1 might modulate 
the localisation of Cyclin A2 during G2 phase. We propose that the change in localisation of 
Cyclin A2 may serve as a regulation layer for Cdk activity in the cytoplasm during G2 phase 
(Paper IV).  
Using endogenously tagged cell lines we were also able to study the behaviour of cyclins upon 
DNA damage (Papers II and III). In particular we focused our study in the dynamics of Cyclin 
B1 during the DNA damage response to understand how cells take cell-fate decisions. Using live-
cell imaging on single cells expressing Cyclin B1-eYFP we found that a few hours after DNA 
damage cells translocate Cyclin B1 to the nucleus in a p53 and p21-dependent manner. Further, 
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the nuclear translocation of Cyclin B1 led to its degradation by APC/CCdh1 leading to the loss of 
G2 identity and irreversible cell cycle exit leading cells to senescence (Paper II).  
Intrigued by the dynamics of Cyclin B1 upon DNA damage as an indicator of cell fate, we 
decided to investigate the mechanism by which cells withdraw from the cell cycle. In paper III 
we explored the function of Cdk activity during an ongoing DNA damage response and found 
that Cdk activity is needed to trigger senescence. In line, we revealed a link between p21 and Cdk 
that seems not to depend on p53. Therefore we propose a model where Cdk activity is maintained 
to either induce repair and checkpoint recovery or to trigger terminal cell cycle exit.  
In conclusion, this thesis addresses the mechanisms of control of cell cycle progression from 
different angles, showing that Cdk activity works as a regulator both for unperturbed cell growth 
and cell fate upon DNA damage. In both situations, cells face an irreversible event, that is mitosis 
or senescence, and Cdk, by modulating the levels and activities of mitotic inducers either in a 
positive or negative way, can determine the outcome of the cell cycle.  
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6 FUTURE PERSPECTIVES 
 
Despite being a relatively young field, the knowledge of the cell cycle has expanded extensively 
since the discovery of cyclins over thirty years ago. However every question answered raises 
many new ones. How cells regulate Cyclin-Cdk complexes is still one of these many unanswered 
questions or rather, incompletely answered ones.  
In particular I have become very interested in the role of Cyclin A2 in the unperturbed cell cycle. 
Firstly, Cyclin A2 is the only cyclin known to form active complexes with two different Cdks in 
unperturbed conditions. Secondly, it localises both to the nucleus and cytoplasm, thus having the 
potential to regulate processes in both subcellular localisations. And last, deregulated Cyclin A2 
is commonly found in several cancers thus making it a potentially interesting target from a 
clinical perspective.  
One of my findings in this thesis is the cell cycle-dependent localisation of Cyclin A2 to the 
cytoplasm. Therefore my main question is: what is the role of cytoplasmic Cyclin A2? One 
potential explanation comes from the spatial regulation of the cell cycle. In this context, the 
cytoplasmic localisation of Cyclin A2 during G2 phase could ensure that phosphorylation of 
Cyclin A2 targets in the cytoplasm only occurs during G2 phase. A potential cytoplasmic target 
of Cyclin A2-containing complexes could be the Cyclin B1-Cdk1 complexes residing in the 
cytoplasm, therefore placing Cyclin A2 in the position to trigger the activation of Cyclin B1-Cdk1 
in the cytoplasm. 
On the other hand, could cytoplasmic Cyclin A2 have a cell cycle-independent function? A report 
recently related Cyclin A2 with RhoA and elements of the cytoskeleton thus suggesting a role for 
Cyclin A2 in modulating cell motility and migration 220.  
It will, therefore, be very interesting to continue the study on Cyclin A2 to shed light both on 
Cdk-dependent and independent functions to understand the full spectrum of processes controlled 
by Cyclin A2.  
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7 POPULAR SCIENCE SUMMARY 
 
All organisms have something in common: they are made of cells. To be precise, they all come from 
one initial cell that gives rise to a large number of cells. The obvious question that rises from this 
statement is therefore: how does one single cell manage to produce the millions of cells that make up a 
whole organism? The simple answer would be “by making copies of themselves”. Indeed, cells are 
able to divide and generate a copy of themselves by going through a process called cell division cycle, 
or simply cell cycle.  
The cell cycle can be divided in four different phases depending on what happens in the cell. The first 
phase called G1 is the time when cells grow and gather signals from their environment to know if 
there are enough nutrients for the cell and if the conditions are positive for the cell to make a copy of 
itself. If a cell receives the appropriate signals, it will start many different processes in order to divide. 
One of the main processes takes place in the next phase of the cell cycle. This phase, called Synthesis 
phase or simply S phase is the time when cells make a copy of all the chromosomes present in the 
nucleus. This will, in practice, create a copy of the instruction book that a cell needs to make copies of 
itself and work properly in its environment and in accordance to its cell type. Once cells finish 
copying their chromosomes they are ready to proceed to the next phase. This phase is called G2 and it 
is a phase for the preparation of the big finale: cell division. During G2 phase, cells make copies of 
other elements and structures in the cell in order to have enough for the copied cell to contain the same 
elements as the initial cell. Also, given that cell division is a very complex process, cells need to 
change their shape and prepare a series of players to make sure that every step needed to make a new 
cell is in place at a certain given time.  
Last, after the 5-6 hours that G2 phase lasts, cells are finally ready to start the making of a new cell. 
This is the beginning of the last phase of the cell cycle: cell division or mitosis. Once cells enter into 
mitosis, they experience a change in shape and become spherical. At two opposite sites of the sphere, 
cells place an organising centre from which a vast number of threads extend towards the centre of the 
sphere. The main aim of these threads, called microtubuli, is to catch the copied chromosomes from 
both sides of the cell. Once this is achieved, microtubuli can pull each copy of each chromosome to 
one side of the cell, which in the end gathers two sets containing all the chromosomes of a cell, one at 
each side of the cell. A few minutes later the centre of the sphere starts to get squeezed to make two 
spheres out of this one. This is the final cut that leads to the birth of a new cell that contains the exact 
same contents as the initial cell.  
The cell cycle could be metaphorically compared to a concert. Like at the performance of a 
symphony, cells count with an orchestra, that is, a series of players that carry out a specific function at 
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a given time. However, regardless of how skilled each and every player is, they need the leadership of 
a conductor to know when they need to perform and most important, how they need to do so. In the 
same way, cells have a group of conductors and assistants, they are called Cyclin-Cdk complexes, and 
each phase of the cell cycle is led by a specific Cyclin-Cdk complex. Cyclin-Cdk complexes are 
composed by two players, a Cdk, which is the responsible of executing protein modifications, and a 
cyclin, which is the partner of Cdk and controls that it does its job at a given time and at a specific 
place. In addition, cells count with different Cyclin-Cdk complexes to control each phase of the cell 
cycle. In other words, each movement of the symphony requires a conductor and a specific assistant to 
make sure the music flows in a beautiful way.  
In this thesis we aimed to understand how cells control the activity of Cyclin-Cdk complexes when 
they are progressing through a normal and healthy cell cycle. Additionally we decided to investigate 
the role of Cyclin-Cdk complexes when a cell receives DNA damage.  
As mentioned above, different Cyclin-Cdk complexes control the series of events occurring during the 
cell cycle. In particular we were interested in complexes containing Cdk1 that can be in complex with 
Cyclin A or Cyclin B. These are the Cyclin-Cdk complexes that ensure that cells create a correct copy 
of the cell, that is, they modulate mitosis. We discovered that cells activate Cdk when they finish 
making a copy of their chromosomes, meaning that the conductor that directs entry into mitosis 
becomes active a few hours before mitosis rather than just a few minutes before mitosis. Our 
discovery revealed that the activation of Cdk1 complexes happens progressively and during a few 
hours. This is in opposition to previous observations that suggested that Cdk1 complexes are activated 
just a few minutes before a cell enters into mitosis.  
In addition we discovered that the end of DNA replication marks a point in the cell cycle when cells 
change the localisation of a specific Cyclin. We found that Cyclin A is in the cytoplasm instead of 
being in the nucleus of all cells before they divide. Bringing back our orchestra example, our findings 
can be summarised as follows: in the first place, the conductor that makes sure that a cell makes its 
own copy correctly arrives at the music hall a few hours before the music needs to be played at its 
maximum volume. Second, the conductor (Cdk) and assistant (Cyclins A or B) start playing their part 
in the symphony communicating with the musicians so that they start playing their part, but only 
softly. Last, we discovered that one of the assistants (Cyclin A) that usually sits in the main offices of 
the music hall (the nucleus) starts to move to other places. Although we still do not understand why 
Cyclin A changes localisation, we think that it could help control the activity of Cdks in different 
locations in the cell.  
The mechanisms described above portray a healthy cell; however, each and every cell in our organism 
is exposed to many different types of damage that can harm the DNA and lead to the appearance of 
mutations. To deal with these situations, cells have different mechanisms to respond and react to DNA 
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damage. In general when cells are damaged they slow down the processes that drive cells to divide. 
That is, Cdk activity decreases to avoid that a cell that has problems in its DNA divides. At the same 
time, cells start to activate repair mechanisms to fix the breaks in the DNA. Once cells have repaired 
all the damage they are ready to continue preparing for cell division. However sometimes the damage 
is too extensive and cells are not able to repair it. In these cases, cells exit the cell cycle, that is, they 
stop proliferating. This mechanism called senescence is a process by which organisms avoid 
propagation of cells with problems, and, in other words, put a barrier to tumour development.  
To understand how cells decide to exit the cell cycle we studied how Cdk activity changes and 
influences the fate of a cell that experiences damage in its DNA. We found that when cells are 
damaged they transport Cyclin B (one of Cdk’s assistants) into the nucleus where it is destroyed. 
Interestingly we discovered that Cdk1 is needed to initiate this process. In other words, after DNA 
damage, even though Cdk activity is decreased, it is enough to activate p21 (a protein that could be 
regarded as a security guard of the cell) that assists Cyclin B to enter into the nucleus. Once Cyclin B 
is destroyed cells start to lose their identity, that is, they forget what phase of the cell cycle they were 
in and they stop proliferating.   
Altogether, in this thesis we have explored the mechanisms present in human cells that make sure that 
cell division happens correctly. One of the hallmarks of cancer is uncontrolled cell division; therefore, 
understanding how cells regulate Cdk activity will give us the knowledge to understand better what 
goes wrong in cells that become cancerous.  
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8 RESUM DE LA TESI 
 
Tots els organismes tenen una característica en comú: estan fets de cèl·lules. En concret, tots vénen 
d’una cèl·lula que dóna lloc als milions de cèl·lules de les que està fet qualsevol organisme. La 
pregunta és, per tant, com pot una sola cèl·lula crear la gran quantitat de cèl·lules que necessita cada 
organisme? La resposta més senzilla és efectivament la realitat: cada cèl·lula és capaç de fer una còpia 
de si mateixa a través d’un procés anomenat cicle cel·lular.  
El cicle cel·lular es pot dividir en quatre fases segons el què succeeix a la cèl·lula a cada fase. En 
primer lloc la fase G1 és la fase durant la qual les cèl·lules creixen responent a estímuls de l’entorn, 
per tant podem considerar G1 com una fase de creixement. A més, si una cèl·lula rep les senyals i 
nutrients necessaris, inicia una sèrie de processos essencials que conduiran a la divisió cel·lular. Un 
d’aquests processos té lloc a la següent fase del cicle: la fase S. La fase S o fase de síntesi és el 
moment del cicle cel·lular en què les cèl·lules fan una còpia de l’ADN present al nucli. Aquest procés 
donarà lloc a la creació d’una còpia de cadascun dels cromosomes al nucli, o en altres paraules, a una 
còpia del manual d’instruccions amb la informació necessària per tal que la cèl·lula filla fruit de la 
divisió cel·lular pugui mantenir tots els processos i funcions de la cèl·lula fins que arribi el moment de 
la següent divisió. Un cop acabada la fase S, comença la fase G2 que és una fase de preparació per 
mitosi. En primer lloc, les cèl·lules segueixen creixent, però a més fan còpies d’altres elements 
presents a la cèl·lula per tal de tenir el contingut suficient per la cèl·lula filla. A part de fer còpies del 
contingut cel·lular, les cèl·lules han de modificar la seva estructura per tal de poder dividir-se. Així, 
passades unes 5 hores de preparació arriba el moment de fer una còpia de la cèl·lula, o el que és el 
mateix, dur a terme la mitosi. En primer lloc les cèl·lules canvien de forma i passen de ser 
relativament planes a ser una esfera. A cada extrem d’aquesta esfera hi ha dues estructures des d’on 
s’estenen els microtúbuls, la funció dels quals és atrapar cadascun dels cromosomes de la cèl·lula per 
tal que cada cèl·lula tingui una còpia de cada cromosoma al final de la mitosi. Un cop tots els 
cromosomes estan enganxats als microtúbuls, aquests comencen a estirar des de cadascun dels pols de 
la cèl·lula donant lloc a una acumulació de cromosomes a cada extrem de la cèl·lula. En aquest 
moment un anell comença a constrènyer el centre de la cèl·lula donant lloc a dues esferes al centre de 
les quals hi ha el nou nucli amb una còpia de cada cromosoma repartit durant mitosi. Finalment, les 
cèl·lules creen noves membranes per definir els nous nuclis i citoplasmes i la mitosi acaba donant lloc 
a dues cèl·lules idèntiques que poden tornar a començar el pas pel cicle cel·lular.  
Per tal d’entendre els mecanismes de control del cicle cel·lular podem imaginar tot el procés com un 
concert, on cada fase del cicle cel·lular es pot comparar a un moviment d’una simfonia. De la mateixa 
manera que a un concert hi ha una orquestra de músics, a la cèl·lula existeix un conjunt de proteïnes 
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que controlen que cada procés passi en un lloc determinat i a un moment determinat. Però encara que 
els músics siguin excepcionals, per tal que la simfonia soni bé l’orquestra necessita un director que 
indiqui quan i com ha de tocar cada músic. Donada la complexitat del cicle cel·lular, les cèl·lules 
humanes tenen molts “directors d’orquestra” diferents. Un dels més importants és un complex de dues 
proteïnes anomenat Ciclina-Cdk. Els complexos Ciclina-Cdk estan formats per una quinasa (una 
proteïna capaç de modificar altres proteïnes i d’aquesta manera, la seva funció) i una unitat 
reguladora, la ciclina. En l’exemple de l’orquestra es podria veure la quinasa Cdk com el director 
d’orquestra i les ciclines com assistents del director. Així doncs, la ciclina, dirigeix l’activitat de la 
quinasa, Cdk. És a dir, l’assistent és l’encarregat de portar al director de l’orquestra al lloc indicat al 
moment necessari per tal de dirigir al grup de músics que s’encarrega de cada moviment de la 
simfonia.  
Aquesta tesi pretén entendre amb més detall l’activitat dels complexos Ciclina-Cdk. En concret, el 
nostre objectiu és entendre els mecanismes a través dels quals les cèl·lules regulen l’activitat de Cdk1, 
la Cdk encarregada de preparar la cèl·lula per la divisió cel·lular conjuntament amb les unitats 
reguladores Ciclina A i ciclina B.  
Estudiant els nivells i l’activitat de diferents proteïnes importants pel cicle cel·lular hem descobert que 
els complexos Ciclina-Cdk s’activen més aviat del que s’havia establert anteriorment. Hem descobert 
que els complexos Ciclina-Cdk comencen a activar-se progressivament un cop acabada la fase S 
enlloc d’activar-se ràpidament minuts abans de la mitosi. Tornant a l’exemple de l’orquestra, hem 
descobert que el director encarregat de l’últim moviment de la simfonia arriba a l’auditori hores abans 
que hagi de dirigir el seu moviment. A més hem descobert que el director comença a dirigir als músics 
per tal que comencin a tocar a un volum molt baix que va incrementant a mesura que avança la 
simfonia. 
A part d’estar interessats en l’activitat de Cdk1 també hem investigat com la Ciclina A es regula 
durant el cicle cel·lular, i hem descobert que un cop acaba la fase de síntesi, la Ciclina A passa d’estar 
present només al nucli a trobar-se al nucli i al citoplasma. Malgrat no haver descobert la funció 
específica de la Ciclina A al citoplasma pensem que aquest canvi de posició podria suposar un canvi 
en l’activitat de Cdk1 al citoplasma, ja que les ciclines regulen l’activitat de les Cdks.  
Tots els mecanismes descrits als paràgrafs anteriors corresponen als mecanismes de control actius en 
cèl·lules sanes sense cap problema, però cal tenir present que totes les cèl·lules de l’organisme poden 
patir lesions a l’ADN que en el pitjor dels casos donen lloc a mutacions. Per tal d’evitar aquestes 
situacions les cèl·lules tenen una sèrie de mecanismes de control que detecten i reparen les lesions a 
l’ADN. La funció principal dels mecanismes de control és bloquejar la progressió a través del cicle 
cel·lular mitjançant una reducció de l’activitat de les Cdks, per tal d’evitar que cèl·lules amb 
mutacions facin còpies d’elles mateixes. Alhora, un cop detectada la lesió, les cèl·lules inicien 
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diversos processos de reparació de l‘ADN. Si les cèl·lules aconsegueixen reparar les lesions poden 
seguir el seu camí cap a la divisió cel·lular. A vegades, però, l’ADN té massa lesions i les cèl·lules no 
el poden reparar. Per tal d’evitar que aquestes cèl·lules es divideixin, els organismes han desenvolupat 
un mecanisme anomenat senescència que impedeix la proliferació de cèl·lules amb lesions a l’ADN. 
La senescència cel·lular és per tant un dels mecanismes dels organismes per tal d’evitar que una 
cèl·lula sana es converteixi potencialment en una cèl·lula tumoral.  
Per tal d’entendre millor el mecanisme pel qual les cèl·lules decideixen deixar de proliferar hem 
investigat com l’activitat de les quinases Cdk afecta el destí de les cèl·lules després d’una lesió a 
l’ADN. Hem descobert que en resposta a una lesió, les cèl·lules transporten la ciclina B des del 
citoplasma al nucli on es recicla. També hem descobert que l’activitat de la Cdk és necessària per tal 
que el transport de la ciclina B tingui lloc. És a dir que tot i que l’activitat de Cdk es redueix en 
resposta a una lesió a l’ADN, encara és suficient per controlar el procés de destrucció de la ciclina B. 
Un cop s’ha reciclat tota la ciclina B, la cèl·lula perd la seva identitat, és a dir que no recorda en quin 
moment del cicle cel·lular es trobava abans de patir el dany genètic. Això fa que les cèl·lules amb 
dany que no s’ha pogut reparar deixin de proliferar i que no puguin contribuir a desenvolupar tumors.  
En resum, durant el desenvolupament d’aquesta tesi hem investigat els mecanismes presents a les 
cèl·lules humanes que permeten que la proliferació de les cèl·lules passi de manera ordenada i 
controlada. Si tenim present que una de les característiques del càncer és la proliferació descontrolada 
de cèl·lules amb mutacions, entendre els processos pels quals les cèl·lules controlen de manera natural 
la divisió cel·lular ens pot ajudar a entendre quin són els mecanismes que estan alterats en els tumors. 
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9 POPULÄRWISSENCHAFTLICHE ZUSAMMENFASSUNG 
 
Alle Lebewesen haben eines gemeinsam: Sie bestehen aus Zellen. Um genauer zu sein stammen diese 
alle von einer Ursprungszelle ab, die eine Vielzahl von Tochterzellen bildet. Die naheliegende Frage 
ist daher: Wie kann eine einzelne Zelle, millionenfache Abkommen produzieren die dann zusammen 
einen gesamten Organismus bilden? Die einfache Antwort hier wäre: „Sie macht Kopien von sich 
selber“. Tatsächlich können Zellen sich Teilen und Kopien von sich selber produzieren indem Sie 
einen Prozess durchlaufen, der sich Zellzyklus nennt.  
Der Zellzyklus kann in vier verschiedene Phasen unterteilt werden, je nachdem welche Prozesse 
gerade in der Zelle ablaufen. Während der ersten, der sogenannte G1-Phase, wächst die Zelle und 
sammelt Information in Ihrer Umgebung um herauszufinden ob genug Nährstoffe für einen 
Teilungsprozess vorhanden sind und ob die Bedingungen günstig sind gerade jetzt eine Kopie von 
sich selber zu produzieren. Wenn die Zelle grünes Licht zum Teilen bekommt, werden  viele 
verschiedene Prozesse eingeleitet. Einer der Hauptprozesse ist die Kopie des Erbmaterials der Zelle, 
der sogenannten Chromosomen in der zweiten Phase des Zellzyklus, der Synthese oder kurz S-Phase. 
Die Chromosomen enthalten all die Information die eine Zelle benötigt um Ihre Aufgaben erfüllen zu 
können um Kopien von sich selber herstellen zu können. Sobald alle Chromosomen kopiert sind geht 
die Zelle in die G2-Phase über, und bereitet sich auf das große Finale, die Zellteilung vor. Während 
der G2-Phase kopiert die Zelle alle andern Bestandteile und Strukturen die eine Zelle zum Überleben 
braucht, damit am Ende jede der Tochterzellen die gleiche Zusammensetzung wie die Ursprungszelle 
hat. Während dieser komplizierten Prozesse verändert die Zelle Ihre Form und produziert einige 
Hilfsstrukturen um sicherzustellen, dass jeder einzelne Schritt auf dem Weg zu einer neuen Zelle zum 
richtigen Zeitpunkt an der richtigen Stelle stattfindet. Nach ungefähr 5 bis 6 Stunden ist die G2 Phase 
beendet und der letzte Teil des Zellyklus kann beginnen, die Mitose-Phase, also die Zweiteilung des 
Erbmaterials. Hierzu verformt sich die Zelle zu einer Kugel und auf den sich gegenüberliegenden 
Seiten der Kugel bilden sich Ankerstrukturen von denen aus Fasern zur Mitte der Kugel gebildet 
werden. Die Aufgabe dieses Spindelapparats und der Spindelfasern ist es das kopierte Erbmaterial 
aufzureihen und je eine Kopie eines jeden Chromosoms zu den beiden Seiten der Zelle zu 
transportieren, sodass sich auf beiden Seiten der Zelle die gleiche Erbinformation wiederfindet. 
Wenige Minuten danach entfernen sich die gegenüberliegenden Pole der Zelle voneinander und die 
Mitte der Zellkugel zieht sich zusammen. Die Tochterzellen trennen sich voneinander und zwei neue 
Zellen mit gleichem Inhalt sind entstanden.  
Der Zellzyklus kann im übertragenden Sinne mit einer Symphonie verglichen werden. Wie bei der 
Aufführung einer Symphonie, ist die Zelle von einem Orchester abhängig in dem eine Reihe von 
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Musikern ganz spezifische Aufgaben zu ganz spezifischen Zeitpunkten erfüllen müssen. Doch 
unabhängig davon wie begabt jeder einzelne Spieler ist, brauchen Sie die Führung eines Dirigenten 
der weiß wann ein jeder zu spielen hat und besonders wichtig mit welcher Lautstärke, welchem 
Ausdruck und Tempo. In gleicher Weise haben Zellen eine Gruppe von Dirigenten und Assistenten, 
die sich Cyclin-Cdk Komplexe nennen und jede Phase des Zellzyklus wird von einem spezifischen 
Cyclin-Cdk Komplex dirigiert. Ein Cyclin-Cdk Komplex besteht aus zwei Bestandteilen, der Cdk, die 
dafür verantwortlich ist Aufgaben auszuführen und Eiweiße so zu verändern, dass sie Ihre 
zugedachten Aufgaben erfüllen können und dem Cyclin, dem Partner der Cdk, welches dafür sorgt, 
dass die Cdk zum richtigen Zeitpunkt am Richtigen Ort aktiv wird. Anders ausgedrückt braucht jeder 
Satz einer Symphonie einen Dirigenten und einen spezifischen Assistenten der dafür sorgt, dass alles 
harmonisch und schön erklingt. 
In dieser Arbeit haben wir versucht zu verstehen wie gesunde Zellen während des Zellzyklus die 
Aktivität der Cyclin-Cdk Komplexe kontrollieren. Außerdem möchten wir herausfinden welche Rolle 
Cyclin-Cdk Komplexe in Zellen mit DNS-Schäden (den Bausteinen der Chromosomen) spielen. 
Wie bereits erwähnt kontrollieren verschiedene Cyclin-Cdk Komplexe die verschiedenen Phasen des 
Zellzyklus. Wir interessieren uns besonders für Cdk1 welche sowohl einen Komplex mit Cyclin A 
oder Cyclin B bilden kann. Diese sind dafür verantwortlich, dass Zellen eine fehlerfreie Kopie von 
sich selber bilden können. Wir haben herausgefunden, dass Zellen dann Cdk aktivieren wenn diese 
damit fertig sind Ihre Chromosomen zu kopieren, also dass der Dirigent der den Beginn der 
Kernteilung bestimmt schon ein paar Stunden vorher die Bühne betritt. Wir konnten zeigen, dass die 
Cdk Komplexe teilweise schon Stunden vor der eigentlichen Teilung aktiv werden, im Gegensatz zu 
bisherigen Beobachtungen nach denen die Cdk Komplexe lediglich Minuten vorher aktiv werden.  
Außerdem haben wir herausgefunden, dass am Ende des Kopiervorganges des Erbmaterials Cyclin A 
den Zellkern verlässt und nicht wie bisher angenommen dort bis zum Ende der Zellteilung verbleibt.  
Zurück zu unserem Orchester Beispiel. Zum einen haben wir herausgefunden, dass der Dirigent (Cdk) 
der für das große Finale am Ende zuständig ist schon einige Stunden vorher in den Konzertsaal kommt 
und mit Hilfe seines Assistenten (Cyclin A oder B) einigen Musikern die Anweisung gibt ganz leise 
im Hintergrund den letzten Satz einzuleiten. Außerdem haben wir herausgefunden, dass einer der 
Assistenten (Cyclin A) die Bühne verlässt und andere Aufgaben im Konzertsaal übernimmt.      
Obwohl wir noch nicht verstehen, warum Cyclin A den Zellkern verlässt, vermuten wir, dass es eine 
Rolle in der Regulation des Zellzyklus spielt.  
Die oben beschriebenen Mechanismen beschreiben die Vorgänge in einer gesunden Zelle, aber jede 
Zelle unseres Köpers ist ständigen Veränderungen und Schäden die zu Mutationen führen können 
ausgesetzt. Um mit diesen Veränderungen klarzukommen gibt es eine Vielzahl von Mechanismen auf 
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Schäden des Erbmaterials zu reagieren. Ganz allgemein verlangsamt die Zelle die Prozesse die zur 
Zellteilung führen solange bis alle Schäden behoben sind. Das heißt die Aktivität der Cdks wird 
vermindert, sodass Fehler im Erbmaterial nicht weitergegeben werden. Gleichzeitig werden 
Reperaturmechanismen gestartet welche die Schäden reparieren sollen und sobald alle Schäden 
behoben sind kann die Zelle Ihren Teilungsprozess fortsetzen. Sind die Schäden allerdings zu viele 
und nicht reparierbar verlässt die Zelle den Zellzyklus und hört auf sich zu teilen. Diesen Prozess 
nennt man Seneszenz („alt werden“). Damit wird verhindert, dass sich fehlerhafte Zellen weiterhin 
vermehren können was andernfalls zur Bildung von Tumoren führen könnte.  
Um zu verstehen wie Zellen sich entscheiden den Zellzyklus zu verlassen haben wir die Veränderung 
der Cdk Aktivität in Zellen mit Schäden im Erbmaterial untersucht. Wir haben dabei herausgefunden, 
dass geschädigte Zellen Cyclin B (einen der Cdk Assistenten) in den Zellkern transportieren wo es 
dann unbrauchbar gemacht wird. Interessanterweise ist Cdk1 notwendig um diesen Prozess zu starten. 
Anders ausgedrückt: also Folge von Schäden im Erbmaterial kann Cdk den Sicherheitschalter der 
Zelle „p21“ aktivieren, welcher dann Cyclin B hilft in den Kern zu gelangen. Sobald Cyclin B dann 
unbrauchbar gemacht wurde „vergisst“ die Zelle in welchem Teil des Zellzyklus sie gerade war und 
hört auf sich zu teilen.  
Zusammengenommen haben wir in dieser Arbeit dazu beigetragen die Mechanismen im Menschen, 
die für eine funktionierende Zellteilung gebraucht werden genauer zu verstehen. Unkontrollierte 
Zellteilung ist eines der Hauptkennzeichen von Krebs. Daher ist das Verständnis der Regulation und 
Funktion der Cdk wichtig um zu verstehen was in Zellen falsch läuft, die unkontrolliert wachsen und 
Tumore bilden können.    
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